About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.01 (-5.45%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
Atividade de preço de DYN
Último preço
$ 17,010
Variação (24h)
-0,98 USD (5,45%)
Volume
2.31M
Volume (média 4 sem.)
-
Abertura
$ 17,70
Variação do dia
$ 17,01 - $ 17,78
Fechamento anterior
$ 17,99
Último negócio
12 Nov, 9:24 pm GMT+0
Atrasado
12 Nov, 9:24 pm GMT+0
DYN price performance
Atrasado
12 Nov, 9:24 pm GMT+0
DYN details
quote.marketSignals